Author archives: Pablo Ortiz

Image of Pablo Ortiz

Pablo Ortiz graduated in Pharmacy from the University of the Basque Country (UPV/EHU) and received an MSc in Synthetic and Industrial Chemistry from the same university. He then moved to the Netherlands where he received a PhD in Synthetic Organic Chemistry from the University of Groningen. He is currently biopolymer and bioaromatics researcher at the Belgium Institute for Technological Research (Vito)

High-performance supramolecular polymer from a simple molecule

High-performance supramolecular polymer from a simple molecule

Chemistry

By Pablo Ortiz

Turning simple, individual molecules into complex, interconnected materials is the core of polymer chemistry. There is currently an increasing demand for materials with sophisticated properties such as self-healing and reusable adhesivity. However, achieving polymers with such functionalities generally demands higher structural complexity, synthetic difficulty, and cost. Now, a team of chemists has designed a supramolecular […]

Chemicals and fuels from plant waste

Chemicals and fuels from plant waste

BiotechnologyChemistryEnergyMaterials

By Pablo Ortiz

Both the depletion of fossil fuels and the environmental concerns are a powerful drive for the development of sustainable routes to commodity chemicals. Lignocellulose, comprised of lignin, cellulose and hemicellulose, is the ideal candidate, but its inherent complexity hampers its transformation to value-added chemicals. The group of Katalin Barta at the University of Groningen has […]

A light on the horizon: New antibiotic without detectable resistance discovered in uncultured bacteria

A light on the horizon: New antibiotic without detectable resistance discovered in uncultured bacteria

MicrobiologyPharmacy

By Pablo Ortiz

There is a widespread concern about the increasing antibiotic resistance and the limited new drugs to treat infectious diseases, as discussed in a previous post . Consequently, the discovery of a new antibiotic active against a range of bacterial pathogens including Staphylococcus aureus has been greatly welcome, especially because no resistance to it has been […]

At the edge of the cliff: no new antibiotics for multidrug-resistant bacteria

At the edge of the cliff: no new antibiotics for multidrug-resistant bacteria

BiomedicineHealthPharmacy

By Pablo Ortiz

The Ebola outbreak has brought the fear of a viral pandemic to the headlines once more, as it happened before with the avian or swine flu. Although viruses-caused infections catch most of attention on the media, the greatest risk to human health comes from other microorganisms, the antibiotic-resistant bacteria. Contrary to viral outbreaks, the threat […]